These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17285738)

  • 1. US Pharmacopeia Council of Experts 2005-2010: work plans, new revision approaches, and other enhancements.
    Williams RL
    AAPS J; 2006; 8(4):E661-4. PubMed ID: 17285738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Official USP Reference Standards: metrology concepts, overview, and scientific issues and opportunities.
    Williams RL; ;
    J Pharm Biomed Anal; 2006 Jan; 40(1):3-15. PubMed ID: 16303277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equivalence studies for complex active ingredients and dosage forms.
    Bhattycharyya L; Dabbah R; Hauck W; Sheinin E; Yeoman L; Williams R
    AAPS J; 2005 Nov; 7(4):E786-812. PubMed ID: 16594632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of USP botanical dietary supplement monographs, 1995-2005.
    Schiff PL; Srinivasan VS; Giancaspro GI; Roll DB; Salguero J; Sharaf MH
    J Nat Prod; 2006 Mar; 69(3):464-72. PubMed ID: 16562859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacopeial harmonization in biotechnology.
    Dabbah R; Grady LT
    Curr Opin Biotechnol; 1998 Jun; 9(3):307-11. PubMed ID: 9687175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probability lower bounds for USP/NF tests.
    Chow SC; Shao J; Wang H
    J Biopharm Stat; 2002 Feb; 12(1):79-92. PubMed ID: 12146721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Life cycle management of analytical methods.
    Parr MK; Schmidt AH
    J Pharm Biomed Anal; 2018 Jan; 147():506-517. PubMed ID: 28666555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-first report.
    World Health Organization
    World Health Organ Tech Rep Ser; 2007; (943):1-156. PubMed ID: 17621973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extemporaneously compounded sterile medications: relevance of new United States pharmacopeial standards to pain clinicians.
    Rusho WJ
    J Pain Palliat Care Pharmacother; 2004; 18(4):69-76. PubMed ID: 15760810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality specifications for articles of botanical origin from the United States Pharmacopeia.
    Ma C; Oketch-Rabah H; Kim NC; Monagas M; Bzhelyansky A; Sarma N; Giancaspro G
    Phytomedicine; 2018 Jun; 45():105-119. PubMed ID: 29778318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collaborative study for the establishment of the WHO 3(rd) International Standard for Endotoxin, the Ph. Eur. endotoxin biological reference preparation batch 5 and the USP Reference Standard for Endotoxin Lot H0K354.
    Findlay L; Desai T; Heath A; Poole S; Crivellone M; Hauck W; Ambrose M; Morris T; Daas A; Rautmann G; Buchheit KH; Spieser JM; Terao E
    Pharmeur Bio Sci Notes; 2015; 2015():73-98. PubMed ID: 26830160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2014; (986):1-387, back cover. PubMed ID: 24964711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities of the USP Analytical Microbiology Expert Committee during the 2000-2005 revision cycle.
    Sutton SV; Knapp JE; Porter D
    PDA J Pharm Sci Technol; 2005; 59(3):157-76. PubMed ID: 16048116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of USP public standards for therapeutic products.
    Bhattacharyya L; Cecil T; Dabbah R; Roll D; Schuber S; Sheinin EB; Williams RL;
    Pharm Res; 2004 Oct; 21(10):1725-31. PubMed ID: 15553215
    [No Abstract]   [Full Text] [Related]  

  • 15. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2005; 929():1-142, backcover. PubMed ID: 16353684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clarifications on the Intended Use of USP <61> Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests.
    Tidswell EC; Tirumalai RS; Gross DD
    PDA J Pharm Sci Technol; 2024 Jun; 78(3):348-357. PubMed ID: 38942475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An inferential procedure for the probability of passing the USP dissolution test.
    Chiang C; Chen CF; Huang MY; Liu JP
    Pharm Stat; 2012; 11(1):32-8. PubMed ID: 21506255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 19. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
    [No Abstract]   [Full Text] [Related]  

  • 20. United States Pharmacopeia activities in the area of vaccines, virology and immunology.
    Morris TS
    Vaccine; 2005 Mar; 23(17-18):2311-3. PubMed ID: 15755617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.